Davidson Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.22M | Sell |
7,224
-196
| -3% | -$87.3K | 0.77% | 39 |
|
|
2025
Q1 | $3.6M | Buy |
7,420
+524
| +8% | +$254K | 0.98% | 10 |
|
|
2024
Q4 | $2.78M | Buy |
6,896
+365
| +6% | +$147K | 0.73% | 47 |
|
|
2024
Q3 | $3.04M | Sell |
6,531
-674
| -9% | -$313K | 0.88% | 37 |
|
|
2024
Q2 | $3.38M | Buy |
7,205
+1,383
| +24% | +$648K | 1.04% | 13 |
|
|
2024
Q1 | $2.43M | Buy |
5,822
+65
| +1% | +$27.2K | 0.78% | 42 |
|
|
2023
Q4 | $2.34M | Buy |
5,757
+786
| +16% | +$320K | 0.85% | 36 |
|
|
2023
Q3 | $1.73M | Sell |
4,971
-22
| -0.4% | -$7.65K | 0.86% | 24 |
|
|
2023
Q2 | $1.76M | Buy |
4,993
+31
| +0.6% | +$10.9K | 0.88% | 17 |
|
|
2023
Q1 | $1.56M | Sell |
4,962
-416
| -8% | -$131K | 0.95% | 14 |
|
|
2022
Q4 | $1.55M | Sell |
5,378
-19
| -0.4% | -$5.49K | 1.07% | 12 |
|
|
2022
Q3 | $1.56M | Buy |
5,397
+200
| +4% | +$57.9K | 0.77% | 10 |
|
|
2022
Q2 | $1.46M | Sell |
5,197
-1,413
| -21% | -$398K | 0.69% | 9 |
|
|
2022
Q1 | $1.73M | Buy |
6,610
+1,604
| +32% | +$419K | 0.64% | 9 |
|
|
2021
Q4 | $1.1M | Sell |
5,006
-1,228
| -20% | -$270K | 0.6% | 63 |
|
|
2021
Q3 | $1.13M | Buy |
6,234
+256
| +4% | +$46.4K | 0.57% | 63 |
|
|
2021
Q2 | $1.21M | Buy |
5,978
+848
| +17% | +$171K | 0.58% | 58 |
|
|
2021
Q1 | $1.1M | Buy |
5,130
+1,939
| +61% | +$417K | 0.58% | 57 |
|
|
2020
Q4 | $754K | Buy |
3,191
+117
| +4% | +$27.6K | 0.42% | 54 |
|
|
2020
Q3 | $836K | Buy |
3,074
+61
| +2% | +$16.6K | 0.53% | 28 |
|
|
2020
Q2 | $875K | Buy |
3,013
+141
| +5% | +$40.9K | 0.77% | 29 |
|
|
2020
Q1 | $683K | Buy |
+2,872
| New | +$683K | 0.97% | 24 |
|